Fangzhou Inc.
PublicFangzhou Inc. is now publicly traded
The data on this page reflects Fangzhou Inc.'s private-market history up to the point it went public, including its funding rounds, valuation, and investors.
Went Public
Jul 9, 2024
Last Round
Series D
Extension
Jan 1, 2023
Est. Valuation at Exit
$1.4B
Total Funding Raised
$366.5M
Company Overview
Fangzhou Inc., operating through its platform Jianke, is a leading online platform for chronic disease management in China. The company provides comprehensive medical services, including follow-up physician consultations and e-prescriptions, alongside online retail pharmacy services. It focuses primarily on patients with chronic conditions such as hypertension, cardiovascular diseases, and respiratory diseases. The platform connects a large base of registered users and doctors, and also offers customized content and marketing solutions to pharmaceutical companies. The company is publicly traded on the Hong Kong Stock Exchange under the ticker 06086.
Sector
Consumer Products and Services (B2C)
AI Layer
Non-AI
Keywords
Fangzhou Inc. Comparables
Compare Fangzhou Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Beijing Yuanxin Technology Group Co., Ltd. | 83% | |
| Miaoshou Doctor | 82% | |
| WeDoctor | 76% |
Fangzhou Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| IPO | Jul 9, 2024 | ||||
| Series D Extension | Jan 1, 2023 | ||||
| Series D | May 1, 2022 | ||||
| Series C | Dec 31, 2020 | ||||
| Series B | Sep 4, 2018 | ||||
Series A Extension | May 14, 2017 |
Fangzhou Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| HBM Healthcare Investments | Series B |
| Crescent Point | Series B, Series A |
| PGA Venture Partners | Series A Extension |
| Shenzhen GTJA Investment Group | Series B |
| Volcanics Venture | Series A Extension |
| Citigroup | IPO |
Fangzhou Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request access